The Research Society for the Study of Diabetes in India (RSSDI) has partnered with the Koita Foundation to establish the RSSDI–Koita Centre for Digital Diabetology (KCDD).  

This partnership is set to advance the use of digital technology in diabetes care and research across India.  

The two entities have formalised their collaboration through a memorandum of understanding (MoU), signed in the presence of RSSDI president Dr Rakesh Sahay, alongside other officials. 

Under this collaborative effort, the organisations, through KCDD, are set to build a healthcare technology team dedicated to defining and implementing national digital programmes in diabetes related management and research.  

The new centre will focus on digital diabetology, with particular emphasis on using digital technologies to enhance patient experiences and diabetes treatment workflows.  

Among the centre’s priorities are the integration of electronic medical records (EMRs), adherence to clinical guidelines, and patient engagement strategies, using artificial intelligence and machine learning (AI/ML) technologies.  

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

In addition, the centre will explore cost-effective solutions in diabetes care by leveraging digital health technologies and data sharing, such as care cost benchmarking and the dissemination of best practices in digital diabetes management. 

KCDD will also expand access to quality diabetes care, particularly in rural and non-urban areas, through telemedicine and other digital tools.  

These technologies will streamline and automate clinical and administrative processes, reducing manual and repetitive tasks. 

The RSSDI–KCDD will focus on continuous education and skill development for healthcare professionals using digital health tools. 

In addition, the centre will collaborate with pharmaceutical companies, healthcare startups, and other stakeholders to drive research and development in the field of diabetes.  

The RSSDI–KCDD will draw on the experiences of the Koita Centre for Digital Oncology, which was opened in collaboration with the National Cancer Grid and Tata Memorial Centre in 2022. 

Sahay said: “Getting access to timely and accurate patient data has been a challenge in diabetes management, and KCDD will help us bridge this important gap. We foresee this centre to become globally relevant in driving the use of digital technology for diabetes management.”